Article info

This article has a correction. Please see:

A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology
Free
  1. Correspondence to:
 Dr R Giusti
 Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, NIH, DHHS, Executive Plaza South, Room 7024, 6120 Executive Boulevard, MSC 7231, Rockville, MD 20852-7231, USA; giustimail.nih.gov
View Full Text

Citation

Giusti RM, Rutter JL, Duray PH, et al
A twofold increase in BRCA mutation related prostate cancer among Ashkenazi Israelis is not associated with distinctive histopathology

Publication history

  • First published October 20, 2003.
Online issue publication 
October 20, 2003

  • .

    Author Correction

    Please note number of errors appear in Table 1. The correct version is available here as a PDF (printer-friendly file). Please note, the changes are highlighted in yellow.

    If you do not have Adobe Reader installed on your computer,
    you can download this free-of-charge, please Click here

     

    Files in this Data Supplement:

    • [View PDF] - Table 1 The frequency of BRCA1/2 Ashkenazi founder mutations among Israeli Ashkenazi men diagnosed with incident prostate cancer 1994-1995, and among men age 50 and over with no history of prostate cancer in the Washington Ashkenazi Study (WAS), and in the Molecular Epidemiology of Colorectal Cancer (MECC) study.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.